While we could not find any meta-analysis concerning the effect of statin treatment upon IL-17α levels, there is a definite association between higher IL-17 concentrations and the odds for developing ischemic heart disease, a pathology that typically benefits from statin therapy [62]. This evidence concerns the gene IL17A and coronary artery disorder.